MY155011A - Hydroxy tetrahydro-naphthalenylurea derivatives - Google Patents
Hydroxy tetrahydro-naphthalenylurea derivativesInfo
- Publication number
- MY155011A MY155011A MYPI20031696A MYPI20031696A MY155011A MY 155011 A MY155011 A MY 155011A MY PI20031696 A MYPI20031696 A MY PI20031696A MY PI20031696 A MYPI20031696 A MY PI20031696A MY 155011 A MY155011 A MY 155011A
- Authority
- MY
- Malaysia
- Prior art keywords
- pain
- treatment
- hydroxy tetrahydro
- tetrahydro
- activity
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/32—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/40—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0210512.0A GB0210512D0 (en) | 2002-05-08 | 2002-05-08 | Tetrahydro-napthalene derivatives |
| GBGB0227262.3A GB0227262D0 (en) | 2002-05-08 | 2002-11-21 | Tetrahydro-naphthalene derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY155011A true MY155011A (en) | 2015-08-28 |
Family
ID=9936269
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI20031696A MY155011A (en) | 2002-05-08 | 2003-05-06 | Hydroxy tetrahydro-naphthalenylurea derivatives |
Country Status (13)
| Country | Link |
|---|---|
| KR (1) | KR101000688B1 (fr) |
| AR (1) | AR039983A1 (fr) |
| CU (1) | CU23422B7 (fr) |
| DO (1) | DOP2003000642A (fr) |
| EC (1) | ECSP045413A (fr) |
| GB (2) | GB0210512D0 (fr) |
| GT (1) | GT200300102A (fr) |
| MA (1) | MA30728B1 (fr) |
| MY (1) | MY155011A (fr) |
| PE (1) | PE20040363A1 (fr) |
| PT (1) | PT1506167E (fr) |
| UA (1) | UA77301C2 (fr) |
| ZA (1) | ZA200408993B (fr) |
-
2002
- 2002-05-08 GB GBGB0210512.0A patent/GB0210512D0/en not_active Ceased
- 2002-11-21 GB GBGB0227262.3A patent/GB0227262D0/en not_active Ceased
-
2003
- 2003-04-28 KR KR1020047017969A patent/KR101000688B1/ko not_active IP Right Cessation
- 2003-04-28 UA UA20041210079A patent/UA77301C2/uk unknown
- 2003-04-28 PT PT03722554T patent/PT1506167E/pt unknown
- 2003-05-05 GT GT200300102A patent/GT200300102A/es unknown
- 2003-05-06 MY MYPI20031696A patent/MY155011A/en unknown
- 2003-05-07 PE PE2003000445A patent/PE20040363A1/es not_active Application Discontinuation
- 2003-05-07 DO DO2003000642A patent/DOP2003000642A/es unknown
- 2003-05-08 AR ARP030101614A patent/AR039983A1/es active IP Right Grant
-
2004
- 2004-11-04 CU CU20040254A patent/CU23422B7/es unknown
- 2004-11-05 MA MA27935A patent/MA30728B1/fr unknown
- 2004-11-05 ZA ZA2004/08993A patent/ZA200408993B/en unknown
- 2004-11-08 EC EC2004005413A patent/ECSP045413A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20040108784A (ko) | 2004-12-24 |
| PE20040363A1 (es) | 2004-07-03 |
| ECSP045413A (es) | 2005-01-03 |
| DOP2003000642A (es) | 2003-11-15 |
| KR101000688B1 (ko) | 2010-12-10 |
| PT1506167E (pt) | 2007-12-10 |
| GB0227262D0 (en) | 2002-12-31 |
| AR039983A1 (es) | 2005-03-09 |
| MA30728B1 (fr) | 2009-10-01 |
| GT200300102A (es) | 2004-03-17 |
| UA77301C2 (en) | 2006-11-15 |
| GB0210512D0 (en) | 2002-06-19 |
| ZA200408993B (en) | 2006-01-25 |
| CU23422B7 (es) | 2009-09-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1082946A1 (en) | Hydroxy tetrahydro-naphthalenyurea derivatives | |
| AU2003294748A1 (en) | Tetrahydro-naphthalene derivatives | |
| IL214198A0 (en) | Compositions and methods for the treatment of diseases and disorders associated with cytokine signaling | |
| WO2005112970A3 (fr) | Utilisation de gelsoline pour le traitement d'infections | |
| EP1893216A4 (fr) | Methodes et preparations pour le traitement de troubles oculaires | |
| LT2444079T (lt) | Kompozicijos ir būdai, skirti akių sutrikimų gydymui | |
| TW200612934A (en) | Quaternary salt CCR2 antagonists | |
| EP2248524A3 (fr) | Agents preventifs/remedes pour l'incontinence de stress et procede de selecetion de ceux-ci | |
| IL207688A0 (en) | Methods of treating skin disorders using an il-31ra antagonist | |
| WO2008005303A3 (fr) | Modulateurs de trpv1 à base de thiazolopyrimidine | |
| WO2007087468A3 (fr) | L'adiponectine pour le traitement de divers troubles | |
| HK1101140A1 (en) | Compositions and methods for treating neurological disorders | |
| WO2010091384A3 (fr) | Inhibiteurs de la cadhérine-11 et méthodes d'utilisation associées | |
| WO2007051785A3 (fr) | Utilisation de sdf-1 pour le traitement et/ou la prevention de maladies neurologiques | |
| IL189009A0 (en) | Methods and compositions for the treatment of neuropathies and related disorders | |
| WO2006081516A3 (fr) | Utilisation de baff pour traiter des pathologies induites par th2 | |
| WO2006109301A3 (fr) | Molecules et procedes d'utilisation correspondants pour le traitement d'affections associees a mcp-1/ccr2 | |
| AU2003288200A1 (en) | Tetrahydro-naphthalene derivatives as vanilloid receptor antagonists | |
| WO2006079068A3 (fr) | Compositions et methodes permettant d'etudier et de traiter des maladies et des troubles inflammatoires | |
| TWI369984B (en) | Pharmaceutical compositions for treatment of overactive bladder associated with neurological disorders | |
| MY155011A (en) | Hydroxy tetrahydro-naphthalenylurea derivatives | |
| IL181713A0 (en) | Use of il-17f for the treatment and/or prevention of neurological diseases | |
| WO2007117289A3 (fr) | Procedes de traitement ou de prevention du dysfonctionnement erectile ou de l'incontinence urinaire | |
| EP2666479A3 (fr) | Utilisations et compositions pour le traitement de l'arthrite rhumatoïde juvénile | |
| PL1776366T3 (pl) | Immunomodulujące oksopirazolocynoliny jako inhibitory CD80 |